Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase S08.020: C5a peptidase

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates

(Topics flags: A Assay, S Structure, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2024
  1. Cullen,R., Tecza,M., Miclot,T., Behan,S., Jain,M., Avink,M.K., Cooney,J.C. and Kagawa,T.F.
    The 1.7 A crystal structure of the C5a peptidase from Streptococcus agalactiae (ScpB) reveals an active site competent for catalysis
    Proteins (2024) 92, 427-431. PubMed  Europe PubMed DOI
  2. Duarte,F., Tecza,M., Gedi,V., McGourty,K. and Hudson,S.P.
    C5a peptidase (ScpA) activity towards human type II and type III interferons
    Cytokine (2024) 180, 156652-156652. PubMed  Europe PubMed DOI
    3. 2023
  3. Kagawa,T.F., Jain,M. and Cooney,J.C.
    X-ray diffraction data for the C5a-peptidase mutant with modified activity and specificity
    Data Brief (2023) 46, 108778-108778. PubMed  Europe PubMed DOI  PMC  EPMC
  4. McKenna,S., Aylward,F., Miliara,X., Lau,R.J., Huemer,C.B., Giblin,S.P., Huse,K.K., Liang,M., Reeves,L., Pearson,M., Xu,Y., Rouse,S.L., Pease,J.E., Sriskandan,S., Kagawa,T.F., Cooney,J. and Matthews,S.
    The protease associated (PA) domain in ScpA from Streptococcus pyogenes plays a role in substrate recruitment
    Biochim Biophys Acta Proteins Proteom (2023) 1871, 140946-140946. PubMed  Europe PubMed DOI
    5. 2022
  5. Jain,M., Tecza,M., Kagawa,T.F. and Cooney,J.C.
    Exosite binding modulates the specificity of the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease
    Comput Struct Biotechnol J (2022) 20, 4860-4869. PubMed  Europe PubMed DOI  PMC  EPMC
    6. 2013
  6. Wei,Z., Fu,Q., Chen,Y., Li,M., Cong,P., Mo,D. and Liu,X.
    Streptococcus equi ssp. zooepidemicus C5a peptidase, a putative invasin, induces protective immune response in mice
    Res Vet Sci (2013) 95, 444-450. PubMed  Europe PubMed DOI
    7. 2012
  7. Kagawa,T.F. and Cooney,J.C.
    C5a peptidase
    [ISSN:978-0-12-407742-3] (2012) 3, 3202-3208. DOI
    8. 2010
  8. Yue,L.Q., Zhou,Y.S. and Zhang,S.M.
    Epitope prediction, fractional expression and immunogenicity of streptococcal C5a peptidase from group B streptococcus
    Chin J Biologicals (2010) 23, 460-465.
    9. 2009
  9. Gleich-Theurer,U., Aymanns,S., Haas,G., Mauerer,S., Vogt,J. and Spellerberg,B.
    Human serum induces streptococcal C5a peptidase expression
    Infect Immun (2009) 77, 3817-3825. PubMed  Europe PubMed DOI  PMC  EPMC
  10. Kagawa,T.F., O'Connell,M.R., Mouat,P., Paoli,M., O'Toole,P.W. and Cooney,J.C.
    Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: a 1.9 A crystal structure of the active form of ScpA
    J Mol Biol (2009) 386, 754-772. PubMed  Europe PubMed DOI  S
    11. 2008
  11. Hull,J.R., Tamura,G.S. and Castner,D.G.
    Interactions of the streptococcal C5a peptidase with human fibronectin
    Acta Biomater (2008) 4, 504-513. PubMed  Europe PubMed DOI  PMC  EPMC
  12. Santillan,D.A., Andracki,M.E. and Hunter,S.K.
    Protective immunization in mice against group B streptococci using encapsulated C5a peptidase
    Am J Obstet Gynecol (2008) 198, 114-114. PubMed  Europe PubMed DOI
    13. 2006
  13. Tamura,G.S., Hull,J.R., Oberg,M.D. and Castner,D.G.
    High-affinity interaction between fibronectin and the Group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity
    Infect Immun (2006) 74, 5739-5746. PubMed  Europe PubMed DOI
  14. [YEAR:24-3-2006]Terao,Y., Yamaguchi,M., Hamada,S. and Kawabata,S.
    Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils
    J Biol Chem (24-3-2006) 281, 14215-14223. PubMed  Europe PubMed DOI
    15. 2005
  15. [YEAR:20-12-2005]Brown,C.K., Gu,Z.Y., Matsuka,Y.V., Purushothaman,S.S., Winter,L.A., Cleary,P.P., Olmsted,S.B., Ohlendorf,D.H. and Earhart,C.A.
    Structure of the streptococcal cell wall C5a peptidase
    Proc Natl Acad Sci U S A (20-12-2005) 102, 18391-18396. PubMed  Europe PubMed DOI  PMC  EPMC  S
  16. Park,H.S. and Cleary,P.P.
    Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils
    Infect Immun (2005) 73, 7878-7886. PubMed  Europe PubMed DOI  PMC  EPMC
    17. 2004
  17. Cleary,P.P. and Matsuka,Y.V.
    C5a peptidase
    [ISSN:0-12-079610-4] (2004) 2, 1808-1810.  V
  18. [YEAR:22-10-2004]Cleary,P.P., Matsuka,Y.V., Huynh,T., Lam,H. and Olmsted,S.B.
    Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice
    Vaccine (22-10-2004) 22, 4332-4341. PubMed  Europe PubMed DOI
  19. Purushothaman,S.S., Park,H.S. and Cleary,P.P.
    Promotion of fibronectin independent invasion by C5a peptidase into epithelial cells in group A Streptococcus
    Indian J Med Res (2004) 119 Suppl, 44-47. PubMed  Europe PubMed
  20. Shet,A., Kaplan,E., Johnson,D. and Cleary,P.P.
    Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections
    Indian J Med Res (2004) 119 Suppl, 95-98. PubMed  Europe PubMed
    21. 2003
  21. [YEAR:15-9-2003]Shet,A., Kaplan,E.L., Johnson,D.R. and Cleary,P.P.
    Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development
    J Infect Dis (15-9-2003) 188, 809-817. PubMed  Europe PubMed DOI
    22. 2002
  22. Anderson,E.T., Wetherell,M.G., Winter,L.A., Olmsted,S.B., Cleary,P.P. and Matsuka,Y.V.
    Processing, stability, and kinetic parameters of C5a peptidase from Streptococcus pyogenes
    Eur J Biochem (2002) 269, 4839-4851. PubMed  Europe PubMed DOI
  23. Beckmann,C., Waggoner,J.D., Harris,T.O., Tamura,G.S. and Rubens,C.E.
    Identification of novel adhesins from group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding
    Infect Immun (2002) 70, 2869-2876. PubMed  Europe PubMed DOI  PMC  EPMC
  24. Cheng,Q., Stafslien,D., Purushothaman,S.S. and Cleary,P.
    The group B streptococcal C5a peptidase is both a specific protease and an invasin
    Infect Immun (2002) 70, 2408-2413. PubMed  Europe PubMed DOI  PMC  EPMC
  25. Cheng,Q., Debol,S., Lam,H., Eby,R., Edwards,L., Matsuka,Y., Olmsted,S.B. and Cleary,P.P.
    Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice
    Infect Immun (2002) 70, 6409-6415. PubMed  Europe PubMed DOI  PMC  EPMC
  26. Koroleva,I.V., Efstratiou,A. and Suvorov,A.N.
    Structural heterogeneity of the streptococcal C5a peptidase gene in Streptococcus pyogenes
    J Bacteriol (2002) 184, 6384-6386. PubMed  Europe PubMed DOI  PMC  EPMC
    27. 2001
  27. Cheng,Q., Carlson,B., Pillai,S., Eby,R., Edwards,L., Olmsted,S.B. and Cleary,P.
    Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci
    Infect Immun (2001) 69, 2302-2308. PubMed  Europe PubMed DOI  PMC  EPMC
    28. 2000
  28. Bohnsack,J.F., Takahashi,S., Hammitt,L., Miller,D.V., Aly,A.A. and Adderson,E.E.
    Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a
    Infect Immun (2000) 68, 5018-5025. PubMed  Europe PubMed DOI  PMC  EPMC
  29. Stafslien,D.K. and Cleary,P.P.
    Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate
    J Bacteriol (2000) 182, 3254-3258. PubMed  Europe PubMed DOI  PMC  EPMC  A
    30. 1999
  30. Siezen,R.J.
    Multi-domain, cell-envelope proteinases of lactic acid bacteria
    Antonie Van Leeuwenhoek (1999) 76, 139-155. PubMed  Europe PubMed DOI
    31. 1997
  31. Chmouryguina,I.I., Suvorov,A.N., Carlson,B. and Cleary,P.
    Structural and functional similarity of C5a-ase enzymes from group A and B streptococci
    Adv Exp Med Biol (1997) 418, 757-759. PubMed  Europe PubMed
  32. Ji,Y., Carlson,B., Kondagunta,A. and Cleary,P.P.
    Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus
    Infect Immun (1997) 65, 2080-2087. PubMed  Europe PubMed  PMC  EPMC
    33. 1996
  33. Chmouryguina,I., Suvorov,A., Ferrieri,P. and Cleary,P.P.
    Conservation of the C5a peptidase genes in group A and B streptococci
    Infect Immun (1996) 64, 2387-2390. PubMed  Europe PubMed  PMC  EPMC
  34. Ji,Y., McLandsborough,L., Kondagunta,A. and Cleary,P.P.
    C5a peptidase alters clearance and trafficking of group A streptococci by infected mice
    Infect Immun (1996) 64, 503-510. PubMed  Europe PubMed  PMC  EPMC
    35. 1995
  35. McLandsborough,L.A. and Cleary,P.P.
    Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of streptococcal C5a peptidase and M protein in OF+ strains
    Dev Biol Stand (1995) 85, 149-152. PubMed  Europe PubMed
    36. 1993
  36. Bohnsack,J.F., Chang,J.K. and Hill,H.R.
    Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species
    Infect Immun (1993) 61, 1421-1426. PubMed  Europe PubMed  PMC  EPMC
    37. 1992
  37. Cleary,P.P., Handley,J., Suvorov,A.N., Podbielski,A. and Ferrieri,P.
    Similarity between the group B and A streptococcal C5a peptidase genes
    Infect Immun (1992) 60, 4239-4244. PubMed  Europe PubMed  PMC  EPMC
  38. Cleary,P.P., Prahbu,U., Dale,J.B., Wexler,D.E. and Handley,J.
    Streptococcal C5a peptidase is a highly specific endopeptidase
    Infect Immun (1992) 60, 5219-5223. PubMed  Europe PubMed  PMC  EPMC
    39. 1991
  39. Bohnsack,J.F., Zhou,X.N., Williams,P.A., Cleary,P.P., Parker,C.J. and Hill,H.R.
    Purification of the proteinase from group B streptococci that inactivates human C5a
    Biochim Biophys Acta (1991) 1079, 222-228. PubMed  Europe PubMed DOI
  40. [YEAR:1-2-1991]Bohnsack,J.F., Mollison,K.W., Buko,A.M., Ashworth,J.C. and Hill,H.R.
    Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus
    Biochem J (1-2-1991) 273, 635-640. PubMed  Europe PubMed  PMC  EPMC
  41. Cleary,P.P., Peterson,J., Chen,C. and Nelson,C.
    Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci
    Infect Immun (1991) 59, 2305-2310. PubMed  Europe PubMed  PMC  EPMC
  42. O'Connor,S.P., Darip,D., Fraley,K., Nelson,C.M., Kaplan,E.L. and Cleary,P.P.
    The human antibody response to streptococcal C5a peptidase
    J Infect Dis (1991) 163, 109-116. PubMed  Europe PubMed
    43. 1990
  43. Chen,C.C. and Cleary,P.P.
    Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes
    J Biol Chem (1990) 265, 3161-3167. PubMed  Europe PubMed
  44. Simpson,W.J., LaPenta,D., Chen,C. and Cleary,P.P.
    Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus
    J Bacteriol (1990) 172, 696-700. PubMed  Europe PubMed  PMC  EPMC
    45. 1989
  45. Chen,C.C. and Cleary,P.P.
    Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene
    Infect Immun (1989) 57, 1740-1745. PubMed  Europe PubMed  PMC  EPMC  E
    46. 1988
  46. [YEAR:15-11-1988]Hill,H.R., Bohnsack,J.F., Morris,E.Z., Augustine,N.H., Parker,C.J., Cleary,P.P. and Wu,J.T.
    Group B streptococci inhibit the chemotactic activity of the fifth component of complement
    J Immunol (15-11-1988) 141, 3551-3556. PubMed  Europe PubMed
    47. 1986
  47. O'Connor,S.P. and Cleary,P.P.
    Localization of the streptococcal C5a peptidase to the surface of group A streptococci
    Infect Immun (1986) 53, 432-434. PubMed  Europe PubMed  PMC  EPMC
    48. 1985
  48. Wexler,D.E., Chenoweth,D.E. and Cleary,P.P.
    Mechanism of action of the group A streptococcal C5a inactivator
    Proc Natl Acad Sci U S A (1985) 82, 8144-8148. PubMed  Europe PubMed  PMC  EPMC
  49. Wexler,D.E. and Cleary,P.P.
    Purification and characteristics of the streptococcal chemotactic factor inactivator
    Infect Immun (1985) 50, 757-764. PubMed  Europe PubMed  PMC  EPMC

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use